2002 | 2003 | 2004 | 2005
ARCHIVES 2002
| Link to the JCU website: |
The detail URL will be provided by David Durrheim. JCU has commenced capturing important publications on LF in PDF format and can be accessed from their website and downloaded using the END NOTE program. The initiative has been endorsed and will need collaboration with Liverpool LF Centre, CDC and WHO to amalgamate these resources from one site and advocated widely to support availability to health professionals and partners to documents that has beneficial effects on their areas of work or attention. It include retrieval of paper based documents and publications and processing them for PDF formats.
|
| Samoa MDA |
Samoa is currently undertaking it's 4th MDA which was officially launched on 29th September 2002. Progress is slow during this busy time of the year as different programmes are competing for the same people in the ministry trying to complete 2002 programmes........
By: Fuatai Maiaua
National Program Cordinator
Samoa
|
| Arrived New Albendazole Stock |
PacELF Office received a total of 725,000 tablets of Albendazole from GSK on 10th October 2002. This supply is for the MDAs in Niue, French Polynesia, Tonga, Vanuatu and Wallis & Futuna during the first half of 2003 and some buffer stock at PacELF Office. We will distribute drugs to the above mentioned countries in the beginning of November.
By Akiko Takamiya, PacELF Operational Officer, PacELF Office, Suva, Fiji
|
| Chyluria |
This August I found a sentence saying that chyluria cannot be cured in a WHO manual at the fourth annual workshop of filariasis elimination in the Pacific region. I will introduce our own experience on the treatment of chyluria through which we solved this issue about 30-50 years ago.
Dr.Katamine of Nagasaki University published in 1952 a series of papers (in Japanese, partially with English summary) which dealt with pathogenesis and a unique surgical treatment of chyluria. He surgically interrupted whole the lymphatic vessels connecting to the affected kidney in 5 chyluria cases. All these cases revealed successful results. Later his method was extensively developed by Drs. Okamoto and Ohi of Kagoshima University. They later summarized their result obtained by surgical stripping and interruption of renal pedicle lymphatics of affected patients during 1952 and 1973. The short-term results were excellent and chyluria ceased in 375 of 383 patients. However, 2 years or later 41 (25.6%) showed recurrence in 160 chyluria cases followed up. However, in comparison with renal pelvic instillation with silver nitrate solution, the surgical treatment revealed better result.
In any endemic areas with filarial chyluria, I recommend to take note our past practice mentioned here.
By Isao Tada, Professor Emeritus, Kyushu University, Japan
|
| The 1st MDA in Fiji |
 |
Mr. Solomone Naivalu, Honorable Minister for Health, Fiji taking the Filariasis tablets during MDA launch 2002. Dr Shigeru Omi, WHO Regional Director for Western Pacific (seated on left) was Chief Guest and also took the medications. (Launch Date: 4th October 2002). The trained public health nurses in MDA, supervised the drug taking by the dignitaries and the public.
By The Fiji National Filariasis Team
|
|
This is the formal notification of MDA 2002 in Fiji from Ministry of Health Fiji
|
3 October 2002
Fiji is a member of the PacELF family with the secretariat based here at Mataika House. It will be launching its first MDA on the 4th October 2002 in the capital city of Suva. The launch will be done by the Minister for Health and the WHO Regional Director for the Western Pacific Region (Dr Shigeru Omi). The launch integrates booth displays of other public health based programs and will be heralded by a march and a band. There will be a designated booths for MDA manned by public health personnel.
2 out the 4 divisions have already commenced the MDA with 3 out of the 19 subdivisions already carried out Their programs with high profile awareness by the chiefs in their area. MDA teams at national levels have completed 17 of the 19 subdivisional training of the health workers and village health personnels.
The MDA will be for October and November 2002 and will be integrated with dengue health promotion activities too. The media has been building up the awareness with good support from international and local organizations for the MDA. The Government of Japan has been the major sponsor. Additional sponsors include the British Government, French Embassy, GSK, Liverpool LF Support Centre, CJ Patel and Co, Makans Drug Pharmaceuticals, Tents and Awnings Ltd, Post Fiji, Asco Motors, FEA, Fiji Development Bank, National Centre for Health Promotion and Colonial Insurance. PacELF and WHO have shown excellent support and advise towards the development of the programme and to the MDA Launch 2002.
Dr Joe Koroivueta
Medical Director, Mataika House,
National Centre for Scientific Services of Virology and Vector Borne Diseases
Ministry of Health
Suva, Fiji
|
|
